Peppermint Secured $4.7 Million for Clinical Billing
The startup uses automated reconciliation to accelerate payments in clinical trial administration.
Updated on Oct. 9, 2026 in Startups
Live Poll
Do you believe modern financial automation improves productivity in complex administrative sectors?
Peppermint has secured $4.7 million in seed funding led by Moxxie to expand its financial automation platform. The startup focuses on clinical trial billing, a domain often constrained by manual reconciliation processes.
Why it matters
By automating the connection between clinical trial management software and financial records, the platform seeks to solve persistent liquidity delays in the healthcare research industry.
Early platform adopters demonstrated three times faster revenue collection and a threefold reduction in overdue invoices. Staff billing time was also reduced by 20% compared to previous manual workflows.
The players
Peppermint
A startup building financial automation tools that integrate with clinical trial management software.
Moxxie
A venture capital firm focused on early-stage technology investments that led the seed funding round.
The details
Peppermint automates financial tracking by ingesting data directly from clinical trial management software, the digital systems used to oversee research protocol progress. The platform cross-references this operational data against payment history and existing trial contracts to identify discrepancies. This process replaces manual verification tasks that traditionally require billing personnel to reconcile research milestones with complex legal agreements.
Timeline
October 8, 2026: Publication of the article.
The Tech Race
This development follows the trends highlighted in the May 2026 Enterprise AI Benchmark Report regarding the rise of specialized agents in healthcare. Peppermint competes by focusing specifically on the high-friction intersection of contract management and clinical research data.
The startup plans to expand its current capabilities to include budget negotiation, expense management, and broader clinical trial analytics. These features will reach research administrators as the firm scales its platform beyond current automated billing functions.
The takeaway
Peppermint is targeting a specific inefficiency in trial administration where automation replaces manual contract reconciliation. Future performance will be measured by the platform's ability to successfully integrate budget negotiation and expense management modules.
Further reading
For more on the latest funding cycles and corporate moves, explore the Startups section.
Live Poll
Do you believe modern financial automation improves productivity in complex administrative sectors?
